Hmcib Spac 3 Stock Current Liabilities
| 226340 Stock | KRW 1,374 25.00 1.85% |
HMCIB SPAC 3 fundamentals help investors to digest information that contributes to HMCIB SPAC's financial success or failures. It also enables traders to predict the movement of HMCIB Stock. The fundamental analysis module provides a way to measure HMCIB SPAC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HMCIB SPAC stock.
HMCIB |
HMCIB SPAC 3 Company Current Liabilities Analysis
HMCIB SPAC's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, HMCIB SPAC 3 has a Current Liabilities of 0.0. This indicator is about the same for the Consumer Non-Cyclicals average (which is currently at 0.0) sector and about the same as Personal Products (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
HMCIB Fundamentals
| Return On Equity | 9.17 | |||
| Return On Asset | 0.0109 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 106.93 B | |||
| Shares Outstanding | 30.1 M | |||
| Shares Owned By Insiders | 54.26 % | |||
| Price To Sales | 1.56 X | |||
| Revenue | 53.81 B | |||
| Gross Profit | 14.44 B | |||
| EBITDA | 1.74 B | |||
| Net Income | (3.96 B) | |||
| Cash And Equivalents | 9.74 B | |||
| Cash Per Share | 992.31 X | |||
| Total Debt | 18.27 B | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 1.93 X | |||
| Cash Flow From Operations | (24.89 B) | |||
| Number Of Employees | 65 | |||
| Beta | 1.02 | |||
| Market Capitalization | 56.1 B | |||
| Total Asset | 83.55 B | |||
| Z Score | 1.8 | |||
| Net Asset | 83.55 B |
About HMCIB SPAC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HMCIB SPAC 3's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HMCIB SPAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HMCIB SPAC 3 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with HMCIB SPAC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HMCIB SPAC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HMCIB SPAC will appreciate offsetting losses from the drop in the long position's value.Moving together with HMCIB Stock
| 0.76 | 214260 | Raphas Co | PairCorr |
| 0.85 | 194700 | NOVAREX CoLtd | PairCorr |
| 0.84 | 293780 | AptaBio Therapeutics | PairCorr |
| 0.68 | 215480 | Daewoo SBI SPAC | PairCorr |
The ability to find closely correlated positions to HMCIB SPAC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HMCIB SPAC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HMCIB SPAC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HMCIB SPAC 3 to buy it.
The correlation of HMCIB SPAC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HMCIB SPAC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HMCIB SPAC 3 moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HMCIB SPAC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in HMCIB Stock
HMCIB SPAC financial ratios help investors to determine whether HMCIB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HMCIB with respect to the benefits of owning HMCIB SPAC security.